Silencing of Kir2 channels by caveolin-1: Cross-talk with cholesterol

Journal of Physiology

Volumn 592, Issue 18, 2014, Pages 4025-4038

  Han, Huazhi ^a   Rosenhouse Dantsker, Avia ^a   Gnanasambandam, Radhakrishnan ^c   Epshtein, Yulia ^a   Chen, Zhenlong ^b   Sachs, Frederick ^c   Minshall, Richard D ^b   Levitan, Irena ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; CHOLESTEROL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; ION CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL ATTACHED PATCH CLAMP; CELL ISOLATION; CELL MEMBRANE; CELL POPULATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE DELETION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MACROPHAGE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; POTASSIUM CONDUCTANCE; POTASSIUM METABOLISM; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SEQUENCE ALIGNMENT; WESTERN BLOTTING; ACTION POTENTIAL; ANIMAL; CELL CULTURE; GENETICS; HEK293 CELL LINE; METABOLISM; PHYSIOLOGY; POINT MUTATION;

ACTION POTENTIALS; ANIMALS; CAVEOLIN 1; CELLS, CULTURED; CHOLESTEROL; HEK293 CELLS; HUMANS; MACROPHAGES; MICE; POINT MUTATION; POTASSIUM CHANNELS, INWARDLY RECTIFYING;

EID: 84907830960     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2014.273177     Document Type: Article

References (44)

1. Bakhshi FR, Mao M, Shajahan AN, Piegeler T, Chen Z, Chernaya O, Sharma T, Elliott WM, Szulcek R, Bogaard HJ, Comhair S, Erzurum S, van Nieuw Amerongen GP, Bonini MG & Minshall RD (2013). Nitrosation-dependent caveolin 1 phosphorylation, ubiquitination, and degradation and its association with idiopathic pulmonary arterial hypertension. Pulm Circ 3, 816-830.
2. + channels. Nat Rev Neurosci 4, 957-967.
3. Byrne DP, Dart C & Rigden DJ (2012). Evaluating caveolin interactions: Do proteins interact with the caveolin scaffolding domain through a widespread aromatic residue-rich motif? PLoS One 7, e44879.
4. Celada A, Gray PW, Rinderknecht E & Schreiber RD (1984). Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity. J ExpMed 160, 55-74.
5. Chen Z, Bakhshi FR, Shajahan AN, Sharma T,MaoM, Trane A, Bernatchez P, van Nieuw Amerongen GP, Bonini MG, Skidgel RA, Malik AB & Minshall RD (2012). Nitric oxide dependent Src activation and resultant caveolin-1 phosphorylation promote eNOS/caveolin-1 binding and eNOS inhibition. Mol Biol Cell 23, 1388-1398.
6. Collins BM, Davis MJ, Hancock JF & Parton RG (2012). Structure-based reassessment of the caveolin signaling model: Do caveolae regulate signaling through caveolin-protein interactions? Dev Cell 23, 11-20.
7. Couet J, Li S, Okamoto T, Ikezu T & Lisanti MP (1997). Identification of peptide and protein ligands for the caveolin-scaffolding domain. J Biol Chem 272, 6525-6533.
8. + channels by cholesterol. PLoS One 6, e19393.
9. Davies LM, Purves GI, Barrett-Jolley R & Dart C (2010). Interaction with caveolin-1 modulates vascular ATP-sensitive potassium (KATP) channel activity. J Physiol 588, 3255-3266.
10. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C,Mende F, Luft FC, Schedl A, Haller H & Kurzchalia TV (2001). Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293, 2449-2452.
11. Epshtein Y, Chopra AP, Rosenhouse-Dantsker A, Kowalsky GB, Logothetis DE & Levitan I (2009). Identification of a C-terminus domain critical for the sensitivity of Kir2.1 channels to cholesterol. Proc Natl Acad Sci U S A 106, 8055-8060.
12. Fang Y, Schram G, Romanenko VG, Shi C, Conti L, Vandenberg CA, Davies PF, Nattel S & Levitan I (2005). Functional expression of Kir2.x in human aortic endothelial cells: the dominant role of Kir2.2. Am J Physiol Cell Physiol 289, C1134-C1144.
13. + channels in aortic endothelium in vitro and in vivo. Circ Res 98, 1064-1071.
14. Garg V, SunW& Hu K (2009). Caveolin-3 negatively regulates recombinant cardiac KATP channels. Biochem Biophys Res Commun 385, 472.
15. + channel Kir2.2. Nature 477, 495.
16. Hibino H, Inanobe A, Furutani K, Murakami S, Findlay I & Kurachi Y (2010). Inwardly rectifying potassium channels: Their structure, function, and physiological roles. Physiol Rev 90, 291-366.
17. Hoop CL, Sivanandam VN, Kodali R, Srnec MN & van derWel PCA (2012). Structural characterization of the caveolin scaffolding domain in association with cholesterol-rich membranes. Biochemistry 51, 90.
18. + channels in hypercholesterolemia. Circ Res 98, 982-984.
19. Johnson DE (1998). Applied Multivariate Statistics. Duxbury Press, Belmont, CA.
20. Joo M, Kwon M, Cho Y-J, Hu N, Pedchenko TV, Sadikot RT, Blackwell TS & Christman JW (2009). Lipopolysaccharide-dependent interaction between PU.1 and cJun determines production of lipocalin-type prostaglandin D synthase and prostaglandin D2 in macrophages. Am J Physiol Lung Cell Mol Physiol 296, L771-L779.
21. Kiss A, Túri A, Müllner N & Tímár J (2000). Caveolin isoforms in resident and elicited rat peritoneal macrophages. Eur J Cell Biol 79, 343-349.
22. Kubo Y, Baldwin TJ, Jan YN & Jan LY (1993). Primary structure and functional expression of a mouse inward rectifier potassium channel. Nature 362, 127-132.
23. Kubo Y, Adelman JP, Clapham DE, Jan LY, Karschin A, Kurachi Y, Lazdunski M, Nichols CG, Seino S & Vandenberg CA (2005). International Union of Pharmacology. LIV. Nomenclature and molecular relationships of inwardly rectifying potassium channels. Pharmacol Rev 57, 509-526.
24. Levitan I, Fang Y, Rosenhouse-Dantsker A & Romanenko V (2010). Cholesterol and ion channels. In Cholesterol Binding and Cholesterol Transport Proteins, ed. Harris JR, pp. 509-549. Springer Science.
25. Lin D-H, Yue P, Pan C, Sun P &Wang W-H (2011).MicroRNA 802 Stimulates ROMK channels by suppressing caveolin-1. J Am Soc Nephrol 22, 1087-1098.
26. Milescu LS, Akk G & Sachs F (2005). Maximum likelihood estimation of ion channel kinetics from macroscopic currents. Biophys J 88, 2494-2515.
27. Nicolai C & Sachs F (2014). Fitting random data to state models with QuB software. Biophysical Reviews In Press.
28. Nishida M, Cadene M, Chait BT & MacKinnon R (2007). Crystal structure of a Kir3.1-prokaryotic Kir channel chimera. EMBO J 26, 4005-4015.
29. Pegan S, Arrabit C, Zhou W, Kwiatkowski W, Collins A, Slesinger PA & Choe S (2005). Cytoplasmic domain structures of Kir2.1 and Kir3.1 show sites for modulating gating and rectification. Nat Neurosci 8, 279-287.
30. Riddle MA, Hughes JM &Walker BR (2011). Role of caveolin-1 in endothelial BKCa channel regulation of vasoreactivity. Am J Physiol Cell Physiol 301, C1404-C1414.
31. + current by optical isomers of cholesterol. Biophys J 83, 3211-3222.
32. Romanenko VG, Fang Y, Byfield F, Travis AJ, Vandenberg CA, Rothblat GH & Levitan I (2004). Cholesterol sensitivity and lipid raft targeting of Kir2.1 channels. Biophys J 87, 3850-3861.
33. Rosenhouse-Dantsker A, Leal-Pinto E, Logothetis DE & Levitan I (2010). Comparative analysis of cholesterol sensitivity of Kir channels: Role of the CD loop. Channels 4, 63-66.
34. Rosenhouse-Dantsker A, Logothetis DE & Levitan I (2011). Cholesterol sensitivity of KIR2.1 is controlled by a belt of residues around the cytosolic pore. Biophys J 100, 381.
35. Rosenhouse-Dantsker A, Noskov S, Durdagi S, Logothetis DE & Levitan I (2013). Identification of novel cholesterol-binding regions in Kir2 channels. J Biol Chem 288, 31154-31164.
36. Sampson LJ, Hayabuchi Y, Standen NB & Dart C (2004). Caveolae localize protein kinase A signalling to arterial ATP-sensitive potassium channels. Circ Res 95, 1012-1018.
37. Singh DK, Rosenhouse-Dantsker A, Nichols CG, Enkvetchakul D & Levitan I (2009). Direct regulation of prokaryotic Kir channel by cholesterol. J Biol Chem 284, 30727-30736.
38. Singh DK, Shentu T-P, Enkvetchakul D & Levitan I (2011). Cholesterol regulates prokaryotic Kir channel by direct binding to channel protein. Biochim Biophys Acta 1808, 2527.
39. Tao X, Avalos JL, Chen J & MacKinnon R (2009). Crystal structure of the eukaryotic strong inward-rectifier K+ channel Kir2.2 at 3.1 Å resolution. Science 326, 1668-1674.
40. + channels to induce IL-1b secretion in macrophages. J Immunol 186, 5236-5243.
41. Tikku S, Epshtein Y, Collins H, Travis AJ, Rothblat GH & Levitan I (2007). Relationship between Kir2.1/Kir2.3 activity and their distribution between cholesterol-rich and cholesterol-poor membrane domains. Am J Physiol Cell Physiol 293, C440-C450.
42. + channel responses during proliferation and activation in macrophages. J Biol Chem 278, 46307-46320.
43. + channels in vascular endothelial cells. J Biol Chem 280, 11656-11664.
44. Williams TM & Lisanti MP (2004). The caveolin genes: from cell biology to medicine. Ann Med 36, 584-595.